{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:42:18Z","timestamp":1793662938434,"version":"4.5.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ehlers-Danlos Support UK Grant ref no.003"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The UK National Diagnostic Service for Ehlers-Danlos Syndromes (EDS) was established in 2009 for the rare types of EDS. Vascular EDS (vEDS) is an inherited connective tissue disorder caused by pathogenic variants in the <jats:italic>COL3A1<\/jats:italic> gene. Associated tissue fragility affects multiple organ systems, increasing the risk of blood vessel dissection and rupture, with potentially fatal consequences. The diagnosis of vEDS has improved with advances in genetic testing, however this is most often suspected following an acute event. We provide data on the clinical features of vEDS for 180 patients (full cohort) seen in our service with confirmed molecular diagnoses. Increased awareness of this rare condition will prompt genetic testing essential to confirm the diagnosis. Outcomes are improved by early diagnosis followed by appropriate management. Fragile connective tissues make invasive procedures potentially dangerous, particularly in an emergency setting. Lifestyle advice from a young age can help acceptance and understanding of the diagnosis and inform choices. There is currently limited evidence for the use of drug therapy to reduce vascular events. We report on the incidence of vascular events in 126 patients (statistical analysis cohort) in our care and the use of medication. Our retrospective data showed that those patients on a long-term angiotensin II receptor blocker and\/or beta-blocker had fewer vascular events than those not on cardiac medication who received the same lifestyle and emergency care advice.<\/jats:p>","DOI":"10.1038\/s41431-023-01343-7","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T02:02:23Z","timestamp":1680055343000},"page":"749-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-2582","authenticated-orcid":false,"given":"Jessica M.","family":"Bowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4474-5883","authenticated-orcid":false,"given":"Monica","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Kammin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-9655","authenticated-orcid":false,"given":"Sylvia","family":"Keigwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel M.","family":"Wheeldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-503X","authenticated-orcid":false,"given":"Glenda J.","family":"Sobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"1343_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jvs.2019.04.487","volume":"71","author":"S Shalhub","year":"2020","unstructured":"Shalhub S, Byers PH, Hicks KL, Coleman DM, Davis FM, De Caridi G, et al. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis. J Vasc Surg. 2020;71:149\u201357.","journal-title":"J Vasc Surg"},{"key":"1343_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 International Classification of the Ehlers\u2013Danlos Syndromes. Am J Med Genet C. 2017;175:8\u201326.","journal-title":"Am J Med Genet C"},{"key":"1343_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJM200003093421001","volume":"342","author":"M Pepin","year":"2000","unstructured":"Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers\u2013Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673\u201380.","journal-title":"N Engl J Med"},{"key":"1343_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/gim.2014.72","volume":"16","author":"MG Pepin","year":"2014","unstructured":"Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers\u2013Danlos syndrome (EDS type IV). Genet Med. 2014;16:881\u20138.","journal-title":"Genet Med"},{"key":"1343_CR5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/ejhg.2015.32","volume":"23","author":"M Frank","year":"2015","unstructured":"Frank M, Albuisson J, Ranque B, Golmard L, Mazzella J, Bal-Theoleyre L, et al. The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers\u2013Danlos syndrome. Eur J Hum Genet. 2015;23:1657\u201364.","journal-title":"Eur J Hum Genet"},{"key":"1343_CR6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/gim.2014.53","volume":"16","author":"ML Murray","year":"2014","unstructured":"Murray ML, Pepin M, Peterson S, Byers PH. Pregnancy-related deaths and complications in women with vascular Ehlers\u2013Danlos syndrome. Genet Med. 2014;16:874\u201380.","journal-title":"Genet Med"},{"key":"1343_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/jgh.14522","volume":"34","author":"M Frank","year":"2019","unstructured":"Frank M, Adham S, Zinzindohou\u00e9 F, Jeunemaitre X. Natural history of gastrointestinal manifestations in vascular Ehlers\u2013Danlos syndrome: A 17-year retrospective review. J Gastroenterol Hepatol. 2019;34:857\u201363.","journal-title":"J Gastroenterol Hepatol"},{"key":"1343_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jvs.2014.01.070","volume":"60","author":"S Shalhub","year":"2014","unstructured":"Shalhub S, Black JH, Cecchi AC, Xu Z, Griswold BF, Safi HJ, et al. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. J Vasc Surg. 2014;60:160\u20139.","journal-title":"J Vasc Surg"},{"key":"1343_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jvs.2019.01.069","volume":"70","author":"S Shalhub","year":"2019","unstructured":"Shalhub S, Byers PH, Hicks KL, Charlton-Ouw K, Zarkowsky D, Coleman DM, et al. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome. J Vasc Surg. 2019;70:1543\u201354.","journal-title":"J Vasc Surg"},{"key":"1343_CR10","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.jacc.2019.01.058","volume":"73","author":"M Frank","year":"2019","unstructured":"Frank M, Adham S, Seigle S, Legrand A, Mirault T, Henneton P, et al. Vascular Ehlers-Danlos syndrome: Long-term observational study. J Am Coll Cardiol. 2019;73:1948\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"1343_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ajmg.a.61094","volume":"179","author":"S Shalhub","year":"2019","unstructured":"Shalhub S, Neptune E, Sanchez DE, Dua A, Arellano N, Mcdonnell NB, et al. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers\u2013Danlos syndrome. Am J Med Genet A. 2019;179:797\u2013802.","journal-title":"Am J Med Genet A."},{"key":"1343_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cjca.2015.11.003","volume":"32","author":"MN Singh","year":"2016","unstructured":"Singh MN, Lacro RV. Recent clinical drug trials evidence in Marfan syndrome and clinical implications. Can J Cardiol. 2016;32:66\u201377.","journal-title":"Can J Cardiol"},{"key":"1343_CR13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/s0140-6736(10)60960-9","volume":"376","author":"KT Ong","year":"2010","unstructured":"Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: A prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376:1476\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(10)60960-9.","journal-title":"Lancet."},{"key":"1343_CR14","unstructured":"Ellard S, Baple EL, Berry I, Forrester N, Turnbull C, Owens MM, et al. ACGS Best Practice Guidelines for Variant Classification. 2019."},{"key":"1343_CR15","unstructured":"Statacorp. 2021. Stata Statistical Software: Release 17. College Station, Tx: Statacorp LLC."},{"key":"1343_CR16","doi-asserted-by":"publisher","first-page":"104592.","DOI":"10.1016\/j.ejmg.2022.104592","volume":"65","author":"S Schirwani","year":"2022","unstructured":"Schirwani S, Van Dijk FS, Cauldwell M, Harrison RS, Kraus A, Brennan P, et al. Amniotic band sequence in vascular Ehlers-Danlos syndrome (EDS): Experience of the EDS National Diagnostic Services in the UK. Eur J Med Genet. 2022t;65:104592. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104592. Epub 2022 Aug 12. PMID: 35964932.","journal-title":"Eur J Med Genet"},{"key":"1343_CR17","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.gim.2022.07.010","volume":"24","author":"SB Stephens","year":"2022","unstructured":"Stephens SB, Russo M, Shalhub S, Beecroft T, Weigand J, Milewicz DM, et al. Evaluating perinatal and neonatal outcomes among children with vascular Ehlers-Danlos syndrome. Genet Med. 2022;24:2134\u201343. https:\/\/doi.org\/10.1016\/j.gim.2022.07.010. Epub 2022 Aug 20. PMID: 35984436.","journal-title":"Genet Med"},{"key":"1343_CR18","unstructured":"Bowen J Abstract 38: Vascular EDS and Pregnancy, Poster Presentation. Proceedings of the 2022 International Scientific Symposium on EDS & HSD. 2022, Sept 14\u201317; Rome."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01343-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T23:03:46Z","timestamp":1688684626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01343-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1038\/s41431-023-01343-7","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study has UK HRA approval (IRAS project ID 307347). The statistical analysis was performed anonymously with approval by the University of Sheffield Research Ethics Committee, application reference number 034199. Informed consent for publication of clinical and molecular data was obtained from all patients and\/ or their guardians included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}